CRNX - Crinetics Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CRNX is currently covered by 8 analysts with an average price target of $81.04. This is a potential upside of $21.02 (35.02%) from yesterday's end of day stock price of $60.02.

Crinetics Pharmaceuticals's activity chart (see below) currently has 23 price targets and 62 ratings on display. The stock rating distribution of CRNX is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 70.88% with an average time for these price targets to be met of 377.7 days.

Highest price target for CRNX is $90, Lowest price target is $54, average price target is $81.04.

Most recent stock forecast was given by JONATHAN WOLLEBEN from JMP on 27-Sep-2024. First documented stock forecast 13-Aug-2018.

Currently out of the existing stock ratings of CRNX, 47 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$80

$19.31 (31.82%)

$80

1 months 18 days ago
(27-Sep-2024)

9/13 (69.23%)

$29.25 (57.64%)

394

Buy

$90

$29.31 (48.29%)

$65

1 months 29 days ago
(16-Sep-2024)

3/6 (50%)

$36.06 (66.85%)

131

Buy

$69

$8.31 (13.69%)

$60

3 months 5 days ago
(09-Aug-2024)

13/14 (92.86%)

$21.36 (44.84%)

322

Buy

$73

$12.31 (20.28%)

$74

3 months 5 days ago
(09-Aug-2024)

4/6 (66.67%)

$25.36 (53.23%)

130

Buy

$54

$-6.69 (-11.02%)

$35

4 months 5 days ago
(09-Jul-2024)

8/8 (100%)

$5.77 (11.96%)

203

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CRNX (Crinetics Pharmaceuticals) average time for price targets to be met?

On average it took 377.7 days on average for the stock forecasts to be realized with a an average price target met ratio 70.88

Which analyst has the current highest performing score on CRNX (Crinetics Pharmaceuticals) with a proven track record?

CHARLES DUNCAN

Which analyst has the most public recommendations on CRNX (Crinetics Pharmaceuticals)?

Charles Duncan works at CANTOR FITZGERALD and has 11 price targets and 8 ratings on CRNX

Which analyst is the currently most bullish on CRNX (Crinetics Pharmaceuticals)?

Josh Schimmer with highest potential upside - $29.31

Which analyst is the currently most reserved on CRNX (Crinetics Pharmaceuticals)?

Joseph Schwartz with lowest potential downside - -$21.69

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?